Cite

HARVARD Citation

    Lescure, F. et al. (2021). Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 9 (5), pp. 522-532. [Online]. 
  
Back to record